Clinical trials

  • Plasmodium falciparum, strain NF54, sporozoites for Malaria
  • Lysergide for Attention deficit hyperactivity disorder
  • Daratumumab for Multiple myeloma
  • Dexamethasone phosphate for Prostate cancer
  • Ozanimod for Relapsing multiple sclerosis
  • AZD6793 for Chronic obstructive pulmonary disease (COPD)
  • acalabrutinib for Chronic lymphocytic leukaemia (CLL) | Small lymphocytic lymphoma (SLL)
  • CXCL12 (expressed by Lactobacillus) for Wound healing | Skin wounds
  • ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT for Kidney transplant | Borderline T-cell rejection (early, kidney transplant)
  • Delgocitinib for Palmoplantar pustulosis
  • Diphtheria toxoid; Tetanus toxoid; Pertussis toxoid; Pertussis filamentous haemagglutinin; Pertussis pertactin; Pertussis fimbrial agglutinogens (FIM) 2 and 3 for Pregnancy
  • N38-(1,3-DIHYDROXYPROPAN-2-YL)-2'-EPI-AMPHOTERICIN B-38-AMIDE for Invasive mould infection